Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions
Business Model:
Revenue: $4M
Employees: 201-500
Address: -
City:
State: other
Zip: -
Country: IL
Integra Holdings is a unique venture fund that combines academic excellence, funding and R&a;D guidance together with a strong and proven business network — the most important elements necessary to bring academic innovation to the market. Focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in their respective fields, Integra takes a hands-on approach by providing our portfolio companies the strategic planning and business development necessary to bring their technology to the market.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2017 | Atox Bio | Series F | 0 |
1/2018 | Rebiotic Rx | Seed Round | - |
5/2021 | Splisense | Series B | 0 |
1/2017 | Nectin Therapeutics | Seed Round | - |
1/2016 | Splisense | Seed Round | - |
1/2018 | BacoCure | Seed Round | - |
1/2014 | NeoProl | Seed Round | - |
1/2014 | Ophrx | Seed Round | - |
5/2021 | Splisense | Series B | 0 |
1/2018 | BacoCure | Seed Round | - |
1/2018 | Rebiotic Rx | Seed Round | - |
12/2017 | Atox Bio | Series F | 0 |
1/2017 | Nectin Therapeutics | Seed Round | - |
1/2016 | Splisense | Seed Round | - |
1/2014 | Ophrx | Seed Round | - |
1/2014 | NeoProl | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|